Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

New power versus old: to beat antivaccination campaigners we need to learn from them-an essay by Kathryn Perera, Henry Timms, and Jeremy Heimans.

Perera K, Timms H, Heimans J.

BMJ. 2019 Nov 21;367:l6447. doi: 10.1136/bmj.l6447. No abstract available.

PMID:
31753812
2.

Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.

Verburg N, Koopman T, Yaqub MM, Hoekstra OS, Lammertsma AA, Barkhof F, Pouwels PJW, Reijneveld JC, Heimans JJ, Rozemuller AJM, Bruynzeel AME, Lagerwaard F, Vandertop WP, Boellaard R, Wesseling P, de Witt Hamer PC.

Neuro Oncol. 2019 Sep 24. pii: noz180. doi: 10.1093/neuonc/noz180. [Epub ahead of print]

PMID:
31550353
3.

Direct comparison of [11C] choline and [18F] FET PET to detect glioma infiltration: a diagnostic accuracy study in eight patients.

Verburg N, Koopman T, Yaqub M, Hoekstra OS, Lammertsma AA, Schwarte LA, Barkhof F, Pouwels PJW, Heimans JJ, Reijneveld JC, Rozemuller AJM, Vandertop WP, Wesseling P, Boellaard R, de Witt Hamer PC.

EJNMMI Res. 2019 Jun 28;9(1):57. doi: 10.1186/s13550-019-0523-8.

4.

The association between preoperative edema and postoperative cognitive functioning and health-related quality of life in WHO grade I meningioma patients.

van Nieuwenhuizen D, Slot KM, Klein M, Verbaan D, Aliaga ES, Heimans JJ, Vandertop WP, Peerdeman SM, Reijneveld JC.

Acta Neurochir (Wien). 2019 Mar;161(3):579-588. doi: 10.1007/s00701-019-03819-2. Epub 2019 Feb 13.

5.

Cognitive functioning and functional brain networks in postoperative WHO grade I meningioma patients.

van Nieuwenhuizen D, Douw L, Klein M, Peerdeman SM, Heimans JJ, Reijneveld JC, Stam CJ, Hillebrand A.

J Neurooncol. 2018 Dec;140(3):605-613. doi: 10.1007/s11060-018-2987-1. Epub 2018 Sep 15.

6.

Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial.

Boele FW, Klein M, Verdonck-de Leeuw IM, Cuijpers P, Heimans JJ, Snijders TJ, Vos M, Bosma I, Tijssen CC, Reijneveld JC; Dutch Society for Neuro-Oncology (LWNO).

J Neurooncol. 2018 Mar;137(1):191-203. doi: 10.1007/s11060-017-2712-5. Epub 2017 Dec 13.

7.

Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis.

Verburg N, Hoefnagels FWA, Barkhof F, Boellaard R, Goldman S, Guo J, Heimans JJ, Hoekstra OS, Jain R, Kinoshita M, Pouwels PJW, Price SJ, Reijneveld JC, Stadlbauer A, Vandertop WP, Wesseling P, Zwinderman AH, De Witt Hamer PC.

AJNR Am J Neuroradiol. 2017 Oct;38(10):1884-1891. doi: 10.3174/ajnr.A5368. Epub 2017 Sep 7.

8.

Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20).

Kieffer JM, Postma TJ, van de Poll-Franse L, Mols F, Heimans JJ, Cavaletti G, Aaronson NK; CI-PeriNomS Group.

Qual Life Res. 2017 Nov;26(11):2999-3010. doi: 10.1007/s11136-017-1626-1. Epub 2017 Jun 20.

PMID:
28634676
9.

Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.

Ediebah DE, Reijneveld JC, Taphoorn MJ, Coens C, Zikos E, Aaronson NK, Heimans JJ, Bottomley A, Klein M; EORTC Quality of Life Department and Patient Reported Outcome and Behavioral Evidence (PROBE).

Qual Life Res. 2017 Apr;26(4):869-880. doi: 10.1007/s11136-016-1426-z. Epub 2016 Oct 15.

10.

Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.

Holla FK, Postma TJ, Blankenstein MA, van Mierlo TJM, Vos MJ, Sizoo EM, de Groot M, Uitdehaag BMJ, Buter J, Klein M, Reijneveld JC, Heimans JJ.

J Neurooncol. 2016 Sep;129(3):525-532. doi: 10.1007/s11060-016-2204-z. Epub 2016 Jul 11.

11.

Altered GABAA receptor density and unaltered blood-brain barrier [11C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis.

Froklage FE, Postnov A, Yaqub MM, Bakker E, Boellaard R, Hendrikse NH, Comans EF, Schuit RC, Schober P, Velis DN, Zwemmer J, Heimans JJ, Lammertsma AA, Voskuyl RA, Reijneveld JC.

J Cereb Blood Flow Metab. 2017 Jan;37(1):97-105. Epub 2015 Nov 19.

12.

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide.

Koekkoek JA, Dirven L, Heimans JJ, Postma TJ, Vos MJ, Reijneveld JC, Taphoorn MJ.

J Neurooncol. 2016 Jan;126(2):347-54. doi: 10.1007/s11060-015-1975-y. Epub 2015 Nov 7.

13.

Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study.

Koekkoek JA, Postma TJ, Heimans JJ, Reijneveld JC, Taphoorn MJ.

Support Care Cancer. 2016 Apr;24(4):1633-8. doi: 10.1007/s00520-015-2930-3. Epub 2015 Sep 25.

14.

The association between cognitive functioning and health-related quality of life in low-grade glioma patients.

Boele FW, Zant M, Heine EC, Aaronson NK, Taphoorn MJ, Reijneveld JC, Postma TJ, Heimans JJ, Klein M.

Neurooncol Pract. 2014 Jun;1(2):40-46. Epub 2014 May 6.

15.

Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review.

Koekkoek JA, Kerkhof M, Dirven L, Heimans JJ, Reijneveld JC, Taphoorn MJ.

Neuro Oncol. 2015 Jul;17(7):924-34. doi: 10.1093/neuonc/nov032. Epub 2015 Mar 25. Review.

16.

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.

van Thuijl HF, Mazor T, Johnson BE, Fouse SD, Aihara K, Hong C, Malmström A, Hallbeck M, Heimans JJ, Kloezeman JJ, Stenmark-Askmalm M, Lamfers ML, Saito N, Aburatani H, Mukasa A, Berger MS, Söderkvist P, Taylor BS, Molinaro AM, Wesseling P, Reijneveld JC, Chang SM, Ylstra B, Costello JF.

Acta Neuropathol. 2015 Apr;129(4):597-607. doi: 10.1007/s00401-015-1403-6. Epub 2015 Feb 28.

17.

Health-related quality of life in stable, long-term survivors of low-grade glioma.

Boele FW, Douw L, Reijneveld JC, Robben R, Taphoorn MJ, Aaronson NK, Heimans JJ, Klein M.

J Clin Oncol. 2015 Mar 20;33(9):1023-9. doi: 10.1200/JCO.2014.56.9079. Epub 2015 Feb 9.

PMID:
25667287
18.

Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.

van Thuijl HF, Scheinin I, Sie D, Alentorn A, van Essen HF, Cordes M, Fleischeuer R, Gijtenbeek AM, Beute G, van den Brink WA, Meijer GA, Havenith M, Idbaih A, Hoang-Xuan K, Mokhtari K, Verhaak RG, van der Valk P, van de Wiel MA, Heimans JJ, Aronica E, Reijneveld JC, Wesseling P, Ylstra B.

Genome Biol. 2014 Sep 23;15(9):471. doi: 10.1186/s13059-014-0471-6.

19.

Epilepsy in the end of life phase of brain tumor patients: a systematic review.

Koekkoek JAF, Dirven L, Reijneveld JC, Postma TJ, Grant R, Pace A, Oberndorfer S, Heimans JJ, Taphoorn MJB.

Neurooncol Pract. 2014 Sep;1(3):134-140. doi: 10.1093/nop/npu018. Review.

20.

Symptoms and medication management in the end of life phase of high-grade glioma patients.

Koekkoek JA, Dirven L, Sizoo EM, Pasman HR, Heimans JJ, Postma TJ, Deliens L, Grant R, McNamara S, Stockhammer G, Medicus E, Taphoorn MJ, Reijneveld JC.

J Neurooncol. 2014 Dec;120(3):589-95. doi: 10.1007/s11060-014-1591-2. Epub 2014 Aug 24.

PMID:
25151506
21.

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study.

Koekkoek JA, Kerkhof M, Dirven L, Heimans JJ, Postma TJ, Vos MJ, Bromberg JE, van den Bent MJ, Reijneveld JC, Taphoorn MJ.

BMC Neurol. 2014 Aug 15;14:157. doi: 10.1186/s12883-014-0157-4.

22.

Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide.

Koekkoek JA, Dirven L, Heimans JJ, Postma TJ, Vos MJ, Reijneveld JC, Taphoorn MJ.

J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):366-73. doi: 10.1136/jnnp-2014-308136. Epub 2014 Jul 23.

PMID:
25055819
23.

Symptom management and quality of life in glioma patients.

Boele FW, Klein M, Reijneveld JC, Verdonck-de Leeuw IM, Heimans JJ.

CNS Oncol. 2014 Jan;3(1):37-47. doi: 10.2217/cns.13.65. Review.

24.

End of life care in high-grade glioma patients in three European countries: a comparative study.

Koekkoek JA, Dirven L, Reijneveld JC, Sizoo EM, Pasman HR, Postma TJ, Deliens L, Grant R, McNamara S, Grisold W, Medicus E, Stockhammer G, Oberndorfer S, Flechl B, Marosi C, Taphoorn MJ, Heimans JJ.

J Neurooncol. 2014 Nov;120(2):303-10. doi: 10.1007/s11060-014-1548-5. Epub 2014 Jul 20.

PMID:
25038849
25.

Internet-based guided self-help for glioma patients with depressive symptoms: design of a randomized controlled trial.

Boele FW, Verdonck-de Leeuw IM, Cuijpers P, Reijneveld JC, Heimans JJ, Klein M.

BMC Neurol. 2014 Apr 10;14:81. doi: 10.1186/1471-2377-14-81.

26.

Seizures in patients with high-grade glioma: a serious challenge in the end-of-life phase.

Sizoo EM, Koekkoek JA, Postma TJ, Heimans JJ, Pasman HR, Deliens L, Taphoorn MJ, Reijneveld JC.

BMJ Support Palliat Care. 2014 Mar;4(1):77-80. doi: 10.1136/bmjspcare-2013-000456. Epub 2013 Jul 23.

PMID:
24644775
27.

Health-related quality of life in high-grade glioma patients.

Dirven L, Aaronson NK, Heimans JJ, Taphoorn MJ.

Chin J Cancer. 2014 Jan;33(1):40-5. doi: 10.5732/cjc.013.10214. Review.

28.

The end-of-life phase of high-grade glioma patients: a systematic review.

Sizoo EM, Pasman HR, Dirven L, Marosi C, Grisold W, Stockhammer G, Egeter J, Grant R, Chang S, Heimans JJ, Deliens L, Reijneveld JC, Taphoorn MJ.

Support Care Cancer. 2014 Mar;22(3):847-57. doi: 10.1007/s00520-013-2088-9. Epub 2013 Dec 14. Review.

PMID:
24337718
29.

Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study.

Froklage FE, Oosterbaan LJ, Sizoo EM, de Groot M, Bosma I, Sanchez E, Douw L, Heimans JJ, Reijneveld JC, Lagerwaard FJ, Buter J, Uitdehaag BM, Klein M, Postma TJ.

J Neurooncol. 2014 Jan;116(2):387-94. doi: 10.1007/s11060-013-1310-4. Epub 2013 Nov 22.

PMID:
24264531
30.

Measuring health-related quality of life in high-grade glioma patients at the end of life using a proxy-reported retrospective questionnaire.

Sizoo EM, Dirven L, Reijneveld JC, Postma TJ, Heimans JJ, Deliens L, Pasman HR, Taphoorn MJ.

J Neurooncol. 2014 Jan;116(2):283-90. doi: 10.1007/s11060-013-1289-x. Epub 2013 Oct 29.

PMID:
24162875
31.

Epilepsy surgery outcome and functional network alterations in longitudinal MEG: a minimum spanning tree analysis.

van Dellen E, Douw L, Hillebrand A, de Witt Hamer PC, Baayen JC, Heimans JJ, Reijneveld JC, Stam CJ.

Neuroimage. 2014 Feb 1;86:354-63. doi: 10.1016/j.neuroimage.2013.10.010. Epub 2013 Oct 12.

PMID:
24128736
32.

The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial.

Boele FW, Douw L, de Groot M, van Thuijl HF, Cleijne W, Heimans JJ, Taphoorn MJ, Reijneveld JC, Klein M.

Neuro Oncol. 2013 Oct;15(10):1420-8. doi: 10.1093/neuonc/not102. Epub 2013 Aug 7.

33.

Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study.

Boele FW, Heimans JJ, Aaronson NK, Taphoorn MJ, Postma TJ, Reijneveld JC, Klein M.

J Neurooncol. 2013 Oct;115(1):87-94. doi: 10.1007/s11060-013-1198-z. Epub 2013 Jul 4.

PMID:
23824535
34.

Local polymorphic delta activity in cortical lesions causes global decreases in functional connectivity.

van Dellen E, Hillebrand A, Douw L, Heimans JJ, Reijneveld JC, Stam CJ.

Neuroimage. 2013 Dec;83:524-32. doi: 10.1016/j.neuroimage.2013.06.009. Epub 2013 Jun 12.

PMID:
23769919
35.

Prevention of chemotherapy-induced peripheral neuropathy: a matter of personalized treatment?

Postma TJ, Reijneveld JC, Heimans JJ.

Ann Oncol. 2013 Jun;24(6):1424-6. doi: 10.1093/annonc/mdt173. No abstract available.

PMID:
23696616
36.

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).

Binda D, Vanhoutte EK, Cavaletti G, Cornblath DR, Postma TJ, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Rossi E, Valsecchi MG, Faber CG, Merkies IS; CI-PeriNomS study group, Galimberti S, Lanzani F, Mattavelli L, Piatti ML, Bidoli P, Cazzaniga M, Cortinovis D, Lucchetta M, Campagnolo M, Bakkers M, Brouwer B, Boogerd W, Grant R, Reni L, Piras B, Pessino A, Padua L, Granata G, Leandri M, Ghignotti I, Plasmati R, Pastorelli F, Heimans JJ, Eurelings M, Meijer RJ, Grisold W, Lindeck Pozza E, Mazzeo A, Toscano A, Russo M, Tomasello C, Altavilla G, Penas Prado M, Dominguez Gonzalez C, Dorsey SG.

Eur J Cancer. 2013 Sep;49(13):2910-8. doi: 10.1016/j.ejca.2013.04.004. Epub 2013 May 10.

PMID:
23668917
37.

Neurocognitive functioning and health-related quality of life in patients with radiologically suspected meningiomas.

van Nieuwenhuizen D, Ambachtsheer N, Heimans JJ, Reijneveld JC, Peerdeman SM, Klein M.

J Neurooncol. 2013 Jul;113(3):433-40. doi: 10.1007/s11060-013-1132-4. Epub 2013 May 3.

PMID:
23640137
38.

Local MEG networks: the missing link between protein expression and epilepsy in glioma patients?

Douw L, de Groot M, van Dellen E, Aronica E, Heimans JJ, Klein M, Stam CJ, Reijneveld JC, Hillebrand A.

Neuroimage. 2013 Jul 15;75:195-203. doi: 10.1016/j.neuroimage.2013.02.067. Epub 2013 Mar 16.

PMID:
23507380
39.

The end-of-life phase of high-grade glioma patients: dying with dignity?

Sizoo EM, Taphoorn MJ, Uitdehaag B, Heimans JJ, Deliens L, Reijneveld JC, Pasman HR.

Oncologist. 2013;18(2):198-203. doi: 10.1634/theoncologist.2012-0247. Epub 2013 Jan 18.

40.

Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 β.

Zurolo E, de Groot M, Iyer A, Anink J, van Vliet EA, Heimans JJ, Reijneveld JC, Gorter JA, Aronica E.

J Neuroinflammation. 2012 Dec 28;9:280. doi: 10.1186/1742-2094-9-280.

41.

Levetiracetam improves verbal memory in high-grade glioma patients.

de Groot M, Douw L, Sizoo EM, Bosma I, Froklage FE, Heimans JJ, Postma TJ, Klein M, Reijneveld JC.

Neuro Oncol. 2013 Feb;15(2):216-23. doi: 10.1093/neuonc/nos288. Epub 2012 Dec 11.

42.

Enhancing quality of life and mastery of informal caregivers of high-grade glioma patients: a randomized controlled trial.

Boele FW, Hoeben W, Hilverda K, Lenting J, Calis AL, Sizoo EM, Collette EH, Heimans JJ, Taphoorn MJ, Reijneveld JC, Klein M.

J Neurooncol. 2013 Feb;111(3):303-11. doi: 10.1007/s11060-012-1012-3. Epub 2012 Dec 2.

PMID:
23212677
43.

Improved, personalized treatment of glioma necessitates long-term follow-up of cognitive functioning.

Reijneveld JC, Klein M, Taphoorn MJ, Postma TJ, Heimans JJ.

Pharmacogenomics. 2012 Nov;13(15):1667-9. doi: 10.2217/pgs.12.172. No abstract available.

PMID:
23171329
44.

MEG network differences between low- and high-grade glioma related to epilepsy and cognition.

van Dellen E, Douw L, Hillebrand A, Ris-Hilgersom IH, Schoonheim MM, Baayen JC, De Witt Hamer PC, Velis DN, Klein M, Heimans JJ, Stam CJ, Reijneveld JC.

PLoS One. 2012;7(11):e50122. doi: 10.1371/journal.pone.0050122. Epub 2012 Nov 14.

45.

Genetics and pharmacogenomics of diffuse gliomas.

van Thuijl HF, Ylstra B, Würdinger T, van Nieuwenhuizen D, Heimans JJ, Wesseling P, Reijneveld JC.

Pharmacol Ther. 2013 Jan;137(1):78-88. doi: 10.1016/j.pharmthera.2012.09.002. Epub 2012 Sep 14. Review.

PMID:
22985521
46.

[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein.

Froklage FE, Syvänen S, Hendrikse NH, Huisman MC, Molthoff CF, Tagawa Y, Reijneveld JC, Heimans JJ, Lammertsma AA, Eriksson J, de Lange EC, Voskuyl RA.

EJNMMI Res. 2012 Mar 28;2:12. doi: 10.1186/2191-219X-2-12.

47.

Factors affecting the cerebral network in brain tumor patients.

Heimans JJ, Reijneveld JC.

J Neurooncol. 2012 Jun;108(2):231-7. doi: 10.1007/s11060-012-0814-7. Epub 2012 Feb 14.

48.

Neurological complications of chemotherapy to the peripheral nervous system.

Postma TJ, Heimans JJ.

Handb Clin Neurol. 2012;105:917-36. doi: 10.1016/B978-0-444-53502-3.00032-X. Review. No abstract available.

PMID:
22230542
49.

Connectivity in MEG resting-state networks increases after resective surgery for low-grade glioma and correlates with improved cognitive performance.

van Dellen E, de Witt Hamer PC, Douw L, Klein M, Heimans JJ, Stam CJ, Reijneveld JC, Hillebrand A.

Neuroimage Clin. 2012 Nov 2;2:1-7. doi: 10.1016/j.nicl.2012.10.007. eCollection 2012.

50.

Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment.

de Groot M, Reijneveld JC, Aronica E, Heimans JJ.

Brain. 2012 Apr;135(Pt 4):1002-16. doi: 10.1093/brain/awr310. Epub 2011 Dec 13. Review.

PMID:
22171351

Supplemental Content

Loading ...
Support Center